#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4306	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2316	550.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1822	1822	T	657	T,C	590,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4306	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2316	550.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1556	1556	C	660	C	574	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6698	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3978	505.1	0	.	n	.	0	T695C	SNP	695	695	T	1250	1250	C	558	C,A	482,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6698	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3978	505.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2526	2526	C	653	C	572	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6698	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3978	505.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2600	2600	A	658	A,C	584,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6698	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3978	505.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3152	3152	C	590	C,T	502,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	708	folP	852	852	100.0	folP.l15.c4.ctg.1	1852	114.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1184	1186	AGC	155;155;154	A;G;C	140;140;141	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	1492	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3754	119.1	1	SNP	p	S91F	1	.	.	271	273	TTC	782	784	TTC	140;141;141	T;T;C	122;123;123	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	1492	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3754	119.1	1	SNP	p	D95G	0	.	.	283	285	GAC	794	796	GAC	138;137;138	G,A;A;C	120,1;121;120	gyrA.WHO_G_01105:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	1492	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3754	119.1	1	SNP	p	D95N	0	.	.	283	285	GAC	794	796	GAC	138;137;138	G,A;A;C	120,1;121;120	gyrA.WHO_G_01105:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	510	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1665	91.8	1	SNP	p	G45D	0	.	.	133	135	GGC	648	650	GGC	149;147;146	G;G;C	126;126;126	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	336	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1294	78.0	0	.	n	.	0	A197.	DEL	197	197	A	726	726	A	148	A,T	131,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	1500	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3314	135.8	1	SNP	p	D86N	0	.	.	256	258	GAC	747	749	GAC	165;166;166	G,A;A;C	144,1;141;145	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	1500	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3314	135.8	1	SNP	p	S87I	0	.	.	259	261	AGT	750	752	AGT	166;167;167	A;G;T	143;146;142	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	1500	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3314	135.8	1	SNP	p	S87R	0	.	.	259	261	AGT	750	752	AGT	166;167;167	A;G;T	143;146;142	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	1500	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3314	135.8	1	SNP	p	S87W	0	.	.	259	261	AGT	750	752	AGT	166;167;167	A;G;T	143;146;142	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	1500	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3314	135.8	1	SNP	p	S88P	0	.	.	262	264	TCC	753	755	TCC	167;164;164	T;C;C	142;144;145	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_G_01358c	parE.WHO_G_01358c	1	1	27	1198	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3011	119.5	1	SNP	p	G410V	1	.	.	1228	1230	GTC	1744	1746	GTC	177;176;177	G;T;C	147;146;147	parE.WHO_G_01358c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1441	1443	GCA	144;145;147	G,A,T;C;A	120,1,1;122;123	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1444	1446	ATC	147;147;150	A;T;C	121;121;123	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1456	1458	GTG	147;146;146	G;T;G	123;121;122	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1456	1458	GTG	147;146;146	G;T;G	123;121;122	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1960	1962	ACC	149;149;148	A;C;C	129;128;128	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2014	2016	GCG	148;148;149	G;C;G	132;120;126	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2014	2016	GCG	148;148;149	G;C;G	132;120;126	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2137	2139	GGC	132;131;131	G,C;G;C,T	110,1;114;108,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2146	2148	GGC	134;134;134	G,A;G;C	110,1;113;114	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1076	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2776	115.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2164	2166	CCG	130;129;128	C,G;C;G	103,1;108;104	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1248	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3342	111.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1733	1735	CCG	147;147;147	C;C;G	120;122;123	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	704	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2047	103.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	687	687	C	119	C	106	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	27	852	porB1a	984	984	100.0	porB1a.l6.c17.ctg.1	1932	132.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2580	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5190	149.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	440	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1304	100.9	1	SNP	p	V57M	1	.	.	169	171	ATG	696	698	ATG	180;180;180	A;T;G	164;162;160	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	2748	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2926	281.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
